Ischemic injury triggers a protective microglial phenotype in models of Aβ pathology

Michael Candlish1, Jan Hofmann1, Desirée Brösamle2,3,4,5

  • 1Neurovascular Disorders, Institute of Cell Biology and Neuroscience, Biologicum, Goethe University Frankfurt, Max-von-Laue Str. 13, Frankfurt am Main, Germany.

Insights

Ischemic stroke reprograms microglia in Alzheimer's Disease (AD) models, promoting a neuroprotective phenotype. This response enhances lipid handling and compact amyloid-beta plaque formation, suggesting therapeutic potential for AD.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Microglia, the brain's immune cells, exhibit plasticity and can respond to multiple insults.
  • Alzheimer's Disease (AD) frequently co-occurs with cerebrovascular pathology, such as ischemic stroke.
  • Understanding the interplay between AD and ischemic injury in microglial response to amyloid-beta (Aβ) is crucial.

Purpose of the Study:

  • To investigate the impact of ischemic stroke on microglial responses in the context of cerebral β-amyloidosis.
  • To characterize the microglial phenotype and its functional consequences in comorbid AD and ischemic injury.

Main Methods:

  • Utilized models of cerebral β-amyloidosis and induced ischemic stroke.
  • Analyzed microglial transcriptional states and lipid handling capabilities.
  • Assessed the impact of microglial phenotype on amyloid-beta plaque morphology and characteristics.

Main Results:

  • Ischemic stroke induced a neuroprotective microglial phenotype characterized by ApoE enrichment and enhanced lipid handling.
  • These reprogrammed microglia promoted the formation of compact, relatively inert amyloid-beta plaques.
  • This phenotype resembled that observed in cognitively resilient AD patients.

Conclusions:

  • Microglial response to Aβ pathology is adaptable and can be beneficially reprogrammed by stimuli like ischemic stroke.
  • Specific pathways involving ApoE, complement activation, and lysosomal processing are implicated in this protective microglial function.
  • Targeting these pathways may offer therapeutic strategies to enhance protective microglial functions in Alzheimer's Disease.

Related Concept Videos